Article
von Willebrand disease: what does the future hold?
Blood - 29 Apr 2021
Denis Cécile V, Susen Sophie, Lenting Peter J
Abstract excerpt
von Willebrand disease (VWD) is characterized by its heterogeneous clinical manifestation, which complicates its diagnosis and management. The clinical management of VWD has remained essentially unchanged over the last 30 years or so, using von Willebrand factor (VWF) concentrates, desmopressin, and anti-fibrinolytic agents as main tools to control bleeding. This is in contrast to hemophilia A, for which a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
